4.7 Article

Development of PLGA-Mannosamine Nanoparticles as Oral Protein Carriers

期刊

BIOMACROMOLECULES
卷 14, 期 11, 页码 4046-4052

出版社

AMER CHEMICAL SOC
DOI: 10.1021/bm401141u

关键词

-

资金

  1. Ministry of Education [CSD2006-00012]
  2. Xunta de Galicia
  3. Spanish Ministry of Economy and Competitivity [SAF2011-30337-C02-02]
  4. Region Wallonne (VACCINOR)
  5. FRSM (Belgium)
  6. Spanish Government

向作者/读者索取更多资源

Here we report the development of polymeric nanoparticles, made of poly(lactide-co-glycolide) (PLGA) chemically modified with mannosamine (MN), intended to specifically interact with the intestinal mucosa and facilitate the intestinal transport of proteins. PLGA-MN nanoparticles displayed nanometric size and a negative zeta potential, which was lower than that of the PLGA nanoparticles. This correlate well with the preferential location of the MN group on the nanoparticles surface obtained by X-ray photoelectron spectroscope (XPS). The presence of MN groups in the polymer chain led to a different surface morphology noted by SEM, an increase of the encapsulation of model proteins, and to help stabilizing the nanoparticles in simulated intestinal fluids. Furthermore, the MN modification significantly enhanced the nanoparticle's interaction with the epithelial cells in human intestinal follicle-associated epithelium cell culture model. Overall, the MN modification significantly modifies the properties of PLGA nanoparticles making them more suitable as nanocarriers for oral protein delivery.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Pharmacology & Pharmacy

Recent advances in long-acting drug delivery systems for anticancer drug

Catarina Pacheco, Ana Baiao, Tao Ding, Wenguo Cui, Bruno Sarmento

Summary: The systemic use of chemotherapy for cancer treatment is limited by its toxicity. Drug delivery systems (DDSs) have been designed to avoid systemic toxicity by protecting drugs and controlling drug release. However, the approval of tailored DDSs for clinical use is minimal due to the need for improvement in safety and in vivo activity.

ADVANCED DRUG DELIVERY REVIEWS (2023)

Article Chemistry, Multidisciplinary

Glioblastoma immuno-endothelial multicellular microtissue as a 3D in vitro evaluation tool of anti-cancer nano-therapeutics

Claudia Martins, Catarina Pacheco, Catarina Moreira-Barbosa, Angela Marques-Magalhaes, Sofia Dias, Marco Araujo, Maria J. Oliveira, Bruno Sarmento

Summary: This study generated human GBM heterotypic multicellular tumor microtissues (MCTMs) using high-throughput 3D modeling, which mimicked the spatial organization and biological features of GBM. The bioactivity of tumor-targeted nanoparticles and anti-cancer drugs were evaluated in the MCTMs, and it was found that the targeted nanoparticles exhibited higher cell uptake and anti-proliferative effect.

JOURNAL OF CONTROLLED RELEASE (2023)

Article Biochemistry & Molecular Biology

Two-photon photodynamic therapy based on FRET using tumor-cell targeted riboflavin conjugated graphene quantum dot

Amir Soleimany, Sepideh Khoee, Davoud Dastan, Zhicheng Shi, Shengtao Yu, Bruno Sarmento

Summary: A method utilizing riboflavin-conjugated and amine-functionalized nitrogen-doped graphene quantum dots is proposed to enhance the treatment depth and specific accumulation capability in photodynamic therapy.

JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY (2023)

Article Instruments & Instrumentation

Functionalized zein nanoparticles targeting neonatal Fc receptor to enhance lung absorption of peptides

Fatima Hameedat, Soraia Pinto, Joana Marques, Sofia Dias, Bruno Sarmento

Summary: Peptides have great potential for treating chronic conditions and there are more than 80 peptides available in the global market. However, most of the marketed peptide drugs are administered intravenously or subcutaneously due to their fast degradation and limited absorption through non-invasive routes. In this study, candidate protein delivery systems for pulmonary administration of peptides were developed and characterized. The targeted PEGylated zein nanoparticles (ZNPs) showed promising results in enhancing insulin permeability and are suitable as peptide carriers for pulmonary delivery.

DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2023)

Article Instruments & Instrumentation

Multifunctional nanomedicine strategies to manage brain diseases

Paulo Faria, Catarina Pacheco, Rui Pedro Moura, Bruno Sarmento, Claudia Martins

Summary: Brain diseases pose a significant social and economic burden, and their complexity makes single-drug therapies insufficient. Nanomedicine, with its ability to target the brain and deliver multiple cargos, shows promise in overcoming therapeutic resistance. This review explores the mechanisms of therapeutic resistance in brain diseases, the use of multifunctional nanomedicines to tackle multiple aspects of the disease microenvironment, and the promising therapeutic responses achieved by cutting-edge multifunctional nanomedicines.

DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2023)

Review Environmental Sciences

In vitro data for fire pollutants: contribution of studies using human cell models towards firefighters' occupational

Maria Joao Bessa, Bruno Sarmento, Marta Oliveira, Francisca Rodrigues

Summary: Firefighters are exposed to health-relevant pollutants released during fires, and in vitro studies using human cell models have shown decreased viability, increased oxidative stress, elevated pro-inflammatory cytokines levels, and increased cell death frequencies. However, more research is needed to understand the toxicity mechanisms initiated by firefighting activities and establish occupational exposure limits for firefighters.

JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART B-CRITICAL REVIEWS (2023)

Article Chemistry, Multidisciplinary

Stimuli-Responsive Multifunctional Nanomedicine for Enhanced Glioblastoma Chemotherapy Augments Multistage Blood-to-Brain Trafficking and Tumor Targeting

Claudia Martins, Marco Araujo, Alessio Malfanti, Catarina Pacheco, Stuart J. J. Smith, Bernard Ucakar, Ruman Rahman, Jonathan W. W. Aylott, Veronique Preat, Bruno Sarmento

Summary: Report the development of hypothesis-driven stimuli-responsive nanoparticles (NPs) for glioblastoma (GBM) therapy. These NPs have multifunctional features that overcome the insufficient blood-brain barrier (BBB) trafficking and lack of GBM targeting, two major challenges in anti-GBM treatments. In preclinical studies, the stimuli-responsive NPs effectively targeted GBM cells, enhanced cell uptake, increased cytotoxicity, improved BBB permeability, and demonstrated antitumor efficacy in GBM models.
Review Chemistry, Multidisciplinary

Special Issue: Nanotherapeutics in Women's Health Emerging Nanotechnologies for Triple-Negative Breast Cancer Treatment

Sofia Torres Quintas, Ana Canha-Borges, Maria Jose Oliveira, Bruno Sarmento, Flavia Castro

Summary: Breast cancer is the leading cause of cancer-related deaths in women, with a significant number of cases and fatalities reported globally in 2020. Triple-negative breast cancer (TNBC), which lacks certain receptors, accounts for approximately 20% of all breast cancers and has a more aggressive clinical course, particularly in younger women. Current standard therapy for advanced TNBC is chemotherapy, but its effectiveness is limited and relapse rates are high. However, recent advances in cancer nanomedicine have provided innovative therapeutic options to overcome the drawbacks of conventional therapies. This review summarizes the recent developments in nanomedicine for TNBC treatment, including novel nanoparticle, exosome, and hybrid-based formulations, and discusses their limitations and challenges for future clinical applications.
Review Nanoscience & Nanotechnology

Multi-ligand functionalized blood-to-tumor sequential targeting strategies in the field of glioblastoma nanomedicine

Claudia Martins, Bruno Sarmento

Summary: Glioblastoma (GBM) is a challenging disease with limited treatment options and poor prognosis. The blood-brain barrier (BBB) presents a major obstacle to drug delivery to the brain, and targeting brain-invading tumor cells is crucial for effective therapy. Nanomedicines with multiple ligands have emerged as a promising approach to sequentially target BBB cells and GBM cells, improving therapeutic accumulation at the tumor site. This review provides an overview of the development of multi-ligand functionalized nanomedicines for BBB and GBM dual targeting over the past decade.

WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY (2023)

Article Instruments & Instrumentation

Zein nanoparticles as oral carrier for mometasone furoate delivery

Priscila Zimath, Soraia Pinto, Sofia Dias, Alex Rafacho, Bruno Sarmento

Summary: This study loaded MF into zein NPs and evaluated the potential advantages of oral delivery and the application in treating intestinal inflammatory diseases.

DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2023)

Review Pharmacology & Pharmacy

Delivery Systems in Ocular Retinopathies: The Promising Future of Intravitreal Hydrogels as Sustained-Release Scaffolds

Diana Rafael, Marcelo Guerrero, Adolfo Marican, Diego Arango, Bruno Sarmento, Roser Ferrer, Esteban F. Duran-Lara, Simon J. Clark, Simo Schwartz

Summary: Slow-release delivery systems are crucial for long-term sustained treatments of retinal diseases. Hydrogels, especially temperature-responsive hydrogels, have been studied as promising delivery vehicles for intravitreal injection of retinal therapies.

PHARMACEUTICS (2023)

Article Engineering, Biomedical

Nanoparticles targeting Sialyl-Tn for efficient tyrosine kinase inhibitor delivery in gastric cancer

Francisca Diniz, Sofia Lamas, Hugo Osorio, Paulo Aguiar, Daniela Freitas, Fatima Gartner, Bruno Sarmento, Celso A. Reis, Joana Gomes

Summary: This study demonstrates the potential of using nanoparticles targeting STn for delivering FRT as a therapeutic approach in gastric cancer. The nanoparticles effectively reduced tumor growth, cell proliferation, and tumor necrosis in vivo.

ACTA BIOMATERIALIA (2023)

Editorial Material Biotechnology & Applied Microbiology

Nanomedicine approaches for treating glioblastoma

Claudia Martins, Catarina Pacheco, Paulo Faria, Bruno Sarmento

NANOMEDICINE (2023)

Review Pharmacology & Pharmacy

Targeting Glucose Metabolism in Cancer Cells as an Approach to Overcoming Drug Resistance

Andrea Cunha, Patricia M. A. Silva, Bruno Sarmento, Odilia Queiros

Summary: The Warburg effect is a metabolic shift that leads to acidification of the tumor microenvironment and increased drug resistance. The metabolic differences between cancer and normal cells provide a strategy for new therapies, and nanodrug delivery systems can overcome multidrug resistance.

PHARMACEUTICS (2023)

Review Chemistry, Multidisciplinary

The Material World of 3D-Bioprinted and Microfluidic-Chip Models of Human Liver Fibrosis

Ana Margarida Carvalho, Ruchi Bansal, Cristina C. Barrias, Bruno Sarmento

Summary: Biomaterials are crucial for creating in vitro models of human liver fibrosis, as they allow for a more accurate replication of cell-matrix interactions. These models can provide insights into the development and treatment of liver disease.

ADVANCED MATERIALS (2023)

暂无数据